Literature DB >> 22483737

Radiation Therapy Oncology Group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer.

Karyn A Goodman1, William F Regine, Laura A Dawson, Edgar Ben-Josef, Karin Haustermans, Walter R Bosch, Julius Turian, Ross A Abrams.   

Abstract

PURPOSE: To develop contouring guidelines to be used in the Radiation Therapy Oncology Group protocol 0848, a Phase III randomized trial evaluating the benefit of adjuvant chemoradiation in patients with resected head of pancreas cancer. METHODS AND MATERIALS: A consensus committee of six radiation oncologists with expertise in gastrointestinal radiotherapy developed stepwise contouring guidelines and an atlas for the delineation of the clinical target volume (CTV) in the postoperative treatment of pancreas cancer, based on identifiable regions of interest and margin expansions. Areas at risk for subclinical disease to be included in the CTV were defined, including nodal regions, anastomoses, and the preoperative primary tumor location. Regions of interest that could be reproducibly contoured on postoperative imaging after a pancreaticoduodenectomy were identified. Standardized expansion margins to encompass areas at risk were developed after multiple iterations to determine the optimal margin expansions.
RESULTS: New contouring recommendations based on CT anatomy were established. Written guidelines for the delineation of the postoperative CTV and normal tissues, as well as a Web-based atlas, were developed.
CONCLUSIONS: The postoperative abdomen has been a difficult area for effective radiotherapy. These new guidelines will help physicians create fields that better encompass areas at risk and minimize dose to normal tissues.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22483737      PMCID: PMC6211792          DOI: 10.1016/j.ijrobp.2012.01.022

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  15 in total

1.  Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.

Authors:  Ross A Abrams; Kathryn A Winter; William F Regine; Howard Safran; John P Hoffman; Robert Lustig; Andre A Konski; Al B Benson; John S Macdonald; Tyvin A Rich; Christopher G Willett
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-02-01       Impact factor: 7.038

2.  A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma.

Authors:  Michael W Brown; Holly Ning; Barbara Arora; Paul S Albert; Matthew Poggi; Kevin Camphausen; Deborah Citrin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-05-01       Impact factor: 7.038

3.  Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings.

Authors:  Shoichi Hishinuma; Yoshiro Ogata; Moriaki Tomikawa; Iwao Ozawa; Kaoru Hirabayashi; Seiji Igarashi
Journal:  J Gastrointest Surg       Date:  2006-04       Impact factor: 3.452

4.  Definition of elective lymphatic target volume in ductal carcinoma of the pancreatic head based on histopathologic analysis.

Authors:  Thomas B Brunner; Susanne Merkel; Gerhard G Grabenbauer; Thomas Meyer; Ulrich Baum; Thomas Papadopoulos; Rolf Sauer; Werner Hohenberger
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-15       Impact factor: 7.038

5.  Potential for dose-escalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and gEUD-based cost functions.

Authors:  Aaron C Spalding; Kyung-Wook Jee; Karen Vineberg; Marla Jablonowski; Benedick A Fraass; Charlie C Pan; Theodore S Lawrence; Randall K Ten Haken; Edgar Ben-Josef
Journal:  Med Phys       Date:  2007-02       Impact factor: 4.071

6.  Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation.

Authors:  Stephen R Smalley; Leonard Gunderson; Joel Tepper; James A Martenson; Bruce Minsky; Christopher Willett; Tyvin Rich
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-02-01       Impact factor: 7.038

7.  Patterns of failure after curative resection of pancreatic carcinoma.

Authors:  J F Griffin; S R Smalley; W Jewell; J C Paradelo; R D Reymond; R E Hassanein; R G Evans
Journal:  Cancer       Date:  1990-07-01       Impact factor: 6.860

8.  Evaluation of a radiotherapy protocol based on INT0116 for completely resected gastric adenocarcinoma.

Authors:  Hans T Chung; Thomas P Shakespeare; Christopher J Wynne; Jay J Lu; Rahul K Mukherjee; Michael F Back
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-08-01       Impact factor: 7.038

9.  Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.

Authors:  Edgar Ben-Josef; Anthony F Shields; Ulka Vaishampayan; Vainutis Vaitkevicius; Basil F El-Rayes; Patrick McDermott; Jay Burmeister; Todd Bossenberger; Philip A Philip
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-06-01       Impact factor: 7.038

10.  Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome.

Authors:  Michael T Milano; Steven J Chmura; Michael C Garofalo; Carla Rash; John C Roeske; Phillip P Connell; Oh-Hoon Kwon; Ashesh B Jani; Ruth Heimann
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-06-01       Impact factor: 7.038

View more
  36 in total

1.  Development of a software for quantitative evaluation radiotherapy target and organ-at-risk segmentation comparison.

Authors:  Jayashree Kalpathy-Cramer; Musaddiq Awan; Steven Bedrick; Coen R N Rasch; David I Rosenthal; Clifton D Fuller
Journal:  J Digit Imaging       Date:  2014-02       Impact factor: 4.056

Review 2.  Locally advanced gastroesophageal junction tumor: a treatment dilemma.

Authors:  Noman Ashraf; Sarah Hoffe; Richard Kim
Journal:  Oncologist       Date:  2015-01-05

3.  Comparison between the four-field box and field-in-field techniques for conformal radiotherapy of the esophagus using dose-volume histograms and normal tissue complication probabilities.

Authors:  Farzaneh Allaveisi; Amir Nami Moghadam
Journal:  Jpn J Radiol       Date:  2017-04-18       Impact factor: 2.374

4.  CT-based multi-organ segmentation using a 3D self-attention U-net network for pancreatic radiotherapy.

Authors:  Yingzi Liu; Yang Lei; Yabo Fu; Tonghe Wang; Xiangyang Tang; Xiaojun Jiang; Walter J Curran; Tian Liu; Pretesh Patel; Xiaofeng Yang
Journal:  Med Phys       Date:  2020-08-02       Impact factor: 4.071

5.  Stereotactic body radiation therapy planning with duodenal sparing using volumetric-modulated arc therapy vs intensity-modulated radiation therapy in locally advanced pancreatic cancer: a dosimetric analysis.

Authors:  Rachit Kumar; Aaron T Wild; Mark A Ziegler; Ted K Hooker; Samson D Dah; Phuoc T Tran; Jun Kang; Koren Smith; Jing Zeng; Timothy M Pawlik; Erik Tryggestad; Eric Ford; Joseph M Herman
Journal:  Med Dosim       Date:  2013-03-27       Impact factor: 1.482

6.  The Role of Log Odds of Positive Lymph Nodes in Predicting the Survival after Resection for Ampullary Adenocarcinoma.

Authors:  Cihan Agalar; Anıl Aysal; Tarkan Unek; Tufan Egeli; Mucahit Ozbilgin; Nesrin Akturk; Huseyin Salih Semiz; Tugba Unek; Mesut Akarsu; Müjde Soyturk; Hulya Ellidokuz; Ozgul Sagol; Ibrahim Astarcioglu
Journal:  Pathol Oncol Res       Date:  2019-01-28       Impact factor: 3.201

Review 7.  Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?

Authors:  Michael D Chuong; Drexell H Boggs; Kruti N Patel; William F Regine
Journal:  J Gastrointest Oncol       Date:  2014-06

8.  Quantitative assessment of target delineation variability for thymic cancers: Agreement evaluation of a prospective segmentation challenge.

Authors:  Emma Holliday; Clifton D Fuller; Jayashree Kalpathy-Cramer; Daniel Gomez; Andreas Rimner; Ying Li; Suresh Senan; Lynn D Wilson; Jehee Choi; Ritsuko Komaki; Charles R Thomas
Journal:  J Radiat Oncol       Date:  2015-11-03

9.  Proton therapy may allow for comprehensive elective nodal coverage for patients receiving neoadjuvant radiotherapy for localized pancreatic head cancers.

Authors:  Richard Y Lee; Romaine C Nichols; Soon N Huh; Meng W Ho; Zuofeng Li; Robert Zaiden; Ziad T Awad; Bestoun Ahmed; Bradfors S Hoppe
Journal:  J Gastrointest Oncol       Date:  2013-12

10.  Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planning.

Authors:  Haoming Qiu; Aaron T Wild; Hao Wang; Elliot K Fishman; Ralph H Hruban; Daniel A Laheru; Rachit Kumar; Amy Hacker-Prietz; Richard Tuli; Erik Tryggestad; Richard D Schulick; John L Cameron; Barish H Edil; Timothy M Pawlik; Christopher L Wolfgang; Joseph M Herman
Journal:  Radiother Oncol       Date:  2012-08-08       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.